Summary & Overview
CPT 0718T: Ultrasound-Guided Autologous Cell Injection, Supraspinatus Tendon
CPT code 0718T designates an ultrasound-guided, unilateral injection of specially prepared autologous cells into the supraspinatus tendon of the rotator cuff. This procedure represents a biologic, regenerative approach to treating tendon pathology in the shoulder and is relevant nationally as interest in autologous cell therapies grows across outpatient settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes coverage patterns and coding considerations that affect reimbursement and clinical documentation for this specific regenerative injection procedure.
Readers will learn the clinical context of the service, typical sites of service, and the primary operational considerations for billing CPT code 0718T. The report provides benchmarks where available, highlights relevant policy developments that influence payer handling, and outlines common billing and documentation issues clinics encounter when reporting an ultrasound-guided autologous cell injection into the supraspinatus tendon. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 0718T describes an ultrasound-guided injection of specially prepared autologous cells into the supraspinatus tendon of the rotator cuff. The biologic material is derived from tissue previously harvested from the same patient and is injected to address tendon pathology in the shoulder.
-
Service type: Biologic/autologous cell injection procedure
-
Typical site of service: Outpatient procedure setting such as an ambulatory surgery center or outpatient clinic, performed on a unilateral shoulder (one side).
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old ambulatory patient presents with chronic right lateral shoulder pain and weakness after months of conservative care for a partial-thickness tear of the supraspinatus tendon. Imaging with diagnostic ultrasound and prior MRI confirm a focal degenerative/partial-thickness supraspinatus tendon tear without full-thickness disruption. The interventional musculoskeletal physician discusses an image-guided biologic therapy using autologous, specially prepared cells derived from previously harvested tissue. On the day of service the patient is positioned seated or supine, the right shoulder is prepped and draped in a sterile fashion, and local anesthesia is administered. Under real-time ultrasound guidance, the provider advances a needle into the affected portion of the supraspinatus tendon and injects the prepared autologous cell suspension into the tendon substance. Post-procedure, the patient is observed briefly for immediate complications, given standardized post-procedure instructions for activity modification and physical therapy, and scheduled for follow-up imaging and clinical assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When work required is substantially greater than typical for 0718T (document rationale). |